These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 4136088)

  • 1. Letter: Hypotensive effect of angiotensin-converting-enzyme inhibitor SQ 20,881.
    Gavras H; Brunner HR; Gavras I; Laragh JH
    Lancet; 1974 Aug; 2(7876):353. PubMed ID: 4136088
    [No Abstract]   [Full Text] [Related]  

  • 2. Letter: Hypotension during administration of angiotensin converting enzyme inhibitor SQ 20,881.
    Duhme DW; Sancho J; Athanasoulis C; Haber E; Koch-Weser J
    Lancet; 1974 Mar; 1(7854):408. PubMed ID: 4136922
    [No Abstract]   [Full Text] [Related]  

  • 3. An angiotensin converting-enzyme inhibitor to identify and treat vasoconstrictor and volume factors in hypertensive patients.
    Gavras H; Brunner HR; Laragh JH; Sealey JE; Gavras I; Vukovich RA
    N Engl J Med; 1974 Oct; 291(16):817-21. PubMed ID: 4371298
    [No Abstract]   [Full Text] [Related]  

  • 4. Reduction of pressor effects of angiotensin I in man by synthetic nonapeptide (B.P.P. 9a or SQ 20,881) which inhibits converting enzyme.
    Collier JG; Robinson BF; Vane JR
    Lancet; 1973 Jan; 1(7794):72-4. PubMed ID: 4118651
    [No Abstract]   [Full Text] [Related]  

  • 5. Accentuated vascular and endocrine response to SQ 20881 in hypertension.
    Williams GH; Hollenberg NK
    N Engl J Med; 1977 Jul; 297(4):184-8. PubMed ID: 195203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Editorial: Angiotensin inhibition.
    Chobanian AV
    N Engl J Med; 1974 Oct; 291(16):844-5. PubMed ID: 4371423
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of angiotensin converting enzyme inhibition on blood pressure, plasma renin activity and plasma aldosterone in essential hypertension.
    Gavras H; Gavras I; Textor S; Volicer L; Brunner HR; Rucinska EJ
    J Clin Endocrinol Metab; 1978 Feb; 46(2):220-6. PubMed ID: 220274
    [No Abstract]   [Full Text] [Related]  

  • 8. Angiotensin inhibitors for hypertension.
    Gavras H; Gavras I; Brunner HR
    Compr Ther; 1980 May; 6(5):14-8. PubMed ID: 6155240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of hypertension with angiotensin converting enzyme inhibitors.
    Johnston CI; McGrath BP; Matthews PG; Jackson B
    Clin Exp Pharmacol Physiol Suppl; 1982; 7():135-44. PubMed ID: 6183036
    [No Abstract]   [Full Text] [Related]  

  • 10. New proline-rich oligopeptides from the venom of African adders: Insights into the hypotensive effect of the venoms.
    Kodama RT; Cajado-Carvalho D; Kuniyoshi AK; Kitano ES; Tashima AK; Barna BF; Takakura AC; Serrano SM; Dias-Da-Silva W; Tambourgi DV; Portaro FV
    Biochim Biophys Acta; 2015 Jun; 1850(6):1180-7. PubMed ID: 25688758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute hypotensive transfusion reaction during liver transplantation in a patient on angiotensin converting enzyme inhibitors from low aminopeptidase P activity.
    Doria C; Elia ES; Kang Y; Adam A; Desormeaux A; Ramirez C; Frank A; di Francesco F; Herman JH
    Liver Transpl; 2008 May; 14(5):684-7. PubMed ID: 18433037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renin--angiotensin antagonists and the regulation of blood pressure.
    Samuels AI; Miller ED; Fray JC; Haber E; Barger AC
    Fed Proc; 1976 Nov; 35(13):2512-20. PubMed ID: 185095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endocrine and cardiovascular consequences of angiotensin converting enzyme inhibition.
    Vukovich RA; Willard DA; Brannick LJ
    J Int Med Res; 1977; 5(1):1-9. PubMed ID: 190063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of inhibition of angiotensin I converting enzyme with SQ-14225 on the arterial blood pressure of mongrel dogs.
    Jandhyala BS; Washington GF; Lokhandwala MF
    Res Commun Chem Pathol Pharmacol; 1978 Nov; 22(2):257-65. PubMed ID: 216064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First dose effect of the oral angiotensin converting enzyme inhibitor captopril.
    Fagard R; Amery A; Lijnen P; Staessen J
    Arch Int Pharmacodyn Ther; 1980; Suppl():178-87. PubMed ID: 6251761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of the effects of two angiotensin converting enzyme inhibitors, SQ 14 225 and MK 422 in Na-restricted sheep.
    Nelson MA; Stewart KW; Coghlan JP; Denton DA; Fei DT; Scoggins BA
    Clin Exp Pharmacol Physiol Suppl; 1982; 7():87-91. PubMed ID: 6183038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of inhibition of angiotensin I conversion by three converting enzyme inhibitors in rats.
    Takata Y; Di Nicolantonio R; Hutchinson JS
    Clin Exp Pharmacol Physiol Suppl; 1982; 7():129-34. PubMed ID: 6183035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison between saralsin and converting enzyme inhibitor in hypertensive disease.
    Case DB; Wallace JM; Laragh JH
    Kidney Int Suppl; 1979 Mar; (9):S107-114. PubMed ID: 225598
    [No Abstract]   [Full Text] [Related]  

  • 19. [Chronic treatment of hypertension by an inhibitor of angiotensin converting enzyme].
    Waeber B; Gavras H; Brunner HR; Chappuis P; Turini GA
    Schweiz Med Wochenschr; 1978 Dec; 108(49):1981-3. PubMed ID: 219469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Profound hypotension in a tetraplegic patient following angiotensin-converting enzyme inhibitor lisinopril. Case report.
    Schmitt JK; Koch KS; Midha M
    Paraplegia; 1994 Dec; 32(12):871-4. PubMed ID: 7708426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.